Ambrx Biopharma, Inc. 4 SEC Filings

Filed On	Filing
07 Mar 2024	Form 4: Hermans Kate, Director Disposed of 12,142 Restricted Stock Units (Disposition to Issuer) · Disposed of 75,000 Option to Purchase Common Stock (Disposition to Issuer)
07 Mar 2024	Form 4: Loesberg Janet, Director Disposed of 12,142 Restricted Stock Units (Disposition to Issuer) · Disposed of 45,000 Option to Purchase Common Stock (Disposition to Issuer)
07 Mar 2024	Form 4: O'Connor Daniel J., Director Returned 48,202 shares to the issuer · Disposed of 1,044,643 Restricted Stock Units (Disposition to Issuer) · Disposed of 946,642 Option to Purchase Common Stock (Disposition to Issuer)
07 Mar 2024	Form 4: Glover Stephen C., Director Disposed of 12,142 Restricted Stock Units (Disposition to Issuer) · Disposed of 38,214 Option to Purchase Common Stock (Disposition to Issuer)
07 Mar 2024	Form 4: Aromando Andrew, Chief Operating Officer Disposed of 100,000 Restricted Stock Units (Disposition to Issuer) · Disposed of 426,998 Option to Purchase Common Stock (Disposition to Issuer)
07 Mar 2024	Form 4: Nelson Sonja, Chief Financial Officer Returned 22,936 shares to the issuer · Disposed of 157,143 Restricted Stock Units (Disposition to Issuer) · Disposed of 605,511 Option to Purchase Common Stock (Disposition to Issuer)
07 Mar 2024	Form 4: Dalesandro Margaret, Director Disposed of 27,976 Restricted Stock Units (Disposition to Issuer)
07 Mar 2024	Form 4: Maier Paul V, Director Disposed of 12,142 Restricted Stock Units (Disposition to Issuer) · Disposed of 45,000 Option to Purchase Common Stock (Disposition to Issuer)
11 Dec 2023	Form 4: Aromando Andrew, Chief Operating Officer Received 100,000 shares as a grant or award
11 Dec 2023	Form 4: Nelson Sonja, Chief Financial Officer Received 50,000 shares as a grant or award
11 Dec 2023	Form 4: O'Connor Daniel J., Director Received 750,000 shares as a grant or award
31 Oct 2023	Form 4: Nelson Sonja, Chief Financial Officer Sold 12,778 shares ($125K)
31 Oct 2023	Form 4: O'Connor Daniel J., Director Sold 50,012 shares ($491K)
25 Oct 2023	Form 4: Cormorant Asset Management, Lp, 10% owner and 3 others Bought 1,307,311 shares ($9.14M)

Comments